2017
DOI: 10.1038/npjpcrm.2017.4
|View full text |Cite
|
Sign up to set email alerts
|

Erratum: Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…LABA/LAMA have been underused similarly in a number of studies 14,27,32,33,45. Many studies also show an overprescription of ICS8,10,14,27,32,33,46,47 with worldwide ICS prescription rates ranging from 19.5% to more than 70% and sometimes 80% depending on the country and the population studied. Our study was conducted in a primary care setting but similar nonadherence and overuse of ICS were found in Safka et al’s17 study including patients from tertiary care.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…LABA/LAMA have been underused similarly in a number of studies 14,27,32,33,45. Many studies also show an overprescription of ICS8,10,14,27,32,33,46,47 with worldwide ICS prescription rates ranging from 19.5% to more than 70% and sometimes 80% depending on the country and the population studied. Our study was conducted in a primary care setting but similar nonadherence and overuse of ICS were found in Safka et al’s17 study including patients from tertiary care.…”
Section: Discussionmentioning
confidence: 97%
“…Specifically, GOLD 2018 guidelines recommend long-acting bronchodilators as maintenance therapy while ICS are proposed only for use in patients with severe/very severe disease and/or frequent exacerbations. Evidence suggests that ICS should be prescribed with caution as they are associated with significant adverse events; however, international studies show that ICS are still considered a cornerstone of treatment independently of the GOLD classification/recommendations not only by primary care physicians but also by pulmonologists 810…”
Section: Introductionmentioning
confidence: 99%